These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10693634)

  • 1. Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotension.
    Hurst GC; Somerville KT; Alloway RR; Gaber AO; Stratta RJ
    Clin Transplant; 2000 Feb; 14(1):42-7. PubMed ID: 10693634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
    McClellan KJ; Wiseman LR; Wilde MI
    Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
    Fouad-Tarazi FM; Okabe M; Goren H
    Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia.
    Axelrod FB; Krey L; Glickstein JS; Allison JW; Friedman D
    J Auton Nerv Syst; 1995 Oct; 55(1-2):29-35. PubMed ID: 8690848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child.
    Olgar S; Omeroglu RE
    Pediatr Cardiol; 2007; 28(4):309-10. PubMed ID: 17530320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?
    Cruz DN; Mahnensmith RL; Perazella MA
    Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine: insidious development of urologic adverse effects in patients with spinal cord injury: a report of 2 cases.
    Vaidyanathan S; Soni BM; Hughes PL
    Adv Ther; 2007; 24(4):712-20. PubMed ID: 17901021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of orthostatic hypotension with midodrine and octreotide.
    Hoeldtke RD; Horvath GG; Bryner KD; Hobbs GR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature.
    Barber DB; Rogers SJ; Fredrickson MD; Able AC
    Spinal Cord; 2000 Feb; 38(2):109-11. PubMed ID: 10762185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report.
    Tran L; Brodeur M
    Sr Care Pharm; 2023 Dec; 38(12):501-505. PubMed ID: 38041226
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
    Jankovic J; Gilden JL; Hiner BC; Kaufmann H; Brown DC; Coghlan CH; Rubin M; Fouad-Tarazi FM
    Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
    Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J
    Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
    Grijalva CG; Biaggioni I; Griffin MR; Shibao CA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K
    Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
    Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
    Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
    Smith W; Wan H; Much D; Robinson AG; Martin P
    Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.
    McTavish D; Goa KL
    Drugs; 1989 Nov; 38(5):757-77. PubMed ID: 2480881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine in neurogenic orthostatic hypotension. A new treatment.
    Gilden JL
    Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension.
    Cruz DN
    Expert Opin Pharmacother; 2000 May; 1(4):835-40. PubMed ID: 11249519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.